Chimeric Antigen Receptor Cell Therapy Market Report

Global and Region Chimeric Antigen Receptor Cell Therapy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：217
  • REPORT CODE：GMM1007016
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chimeric Antigen Receptor Cell Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chimeric Antigen Receptor Cell Therapymarket, defines the market attractiveness level of Chimeric Antigen Receptor Cell Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chimeric Antigen Receptor Cell Therapy industry, describes the types of Chimeric Antigen Receptor Cell Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chimeric Antigen Receptor Cell Therapy market and the development prospects and opportunities of Chimeric Antigen Receptor Cell Therapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chimeric Antigen Receptor Cell Therapy market in Chapter 13.

    By Player:

    • Gilead Sciences Inc

    • Nanjing Legend Biotech Co Ltd

    • Novartis AG

    • Bristol-Myers Squibb Co

    • Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Takara Bio Inc

    • Cellular Biomedicine Group Inc

    • NantKwest Inc

    • Kite Pharma Inc

    • Daiichi Sankyo Co Ltd

    • Autolus Therapeutics Plc

    • Cell Medica Ltd

    • Juno Therapeutics Inc

    • CARsgen Therapeutics Ltd

    • Celyad SA

    • Beijing Immunochina Medical Science & Technology Co Ltd

    • Hangzhou Converd Co Ltd

    • Ono Pharmaceutical Co Ltd

    • Sorrento Therapeutics Inc

    • Hebei Senlang Biotechnology Inc Ltd

    • Bellicum Pharmaceuticals Inc

    • Guangzhou Anjie Biomedical Technology Co Ltd

    • Celgene Corp

    • Fosun Pharmaceutical AG

    • Celularity Inc

    • Nkarta Inc

    • Amgen Inc

    • bluebird bio Inc

    • HRAIN Biotechnology Co Ltd

    By Type:

    • Monotherapy

    • Combination Therapy

    By End-User:

    • Acute Leukemia

    • Non-hodgkin's Lymphoma

    • Multiple Myeloma

    • Transplant Rejection

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chimeric Antigen Receptor Cell Therapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chimeric Antigen Receptor Cell Therapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chimeric Antigen Receptor Cell Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chimeric Antigen Receptor Cell Therapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chimeric Antigen Receptor Cell Therapy Market Analysis and Outlook to 2022

    • 7.1 Global Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    • 7.2 United States Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    • 7.3 Europe Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    • 7.4 China Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    • 7.5 Japan Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    • 7.6 India Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    • 7.7 South Korea Chimeric Antigen Receptor Cell Therapy Consumption (2017-2022)

    8 Region and Country-wise Chimeric Antigen Receptor Cell Therapy Market Analysis and Outlook to 2028

    • 8.1 Global Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    • 8.2 United States Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    • 8.3 Europe Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    • 8.4 China Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    • 8.5 Japan Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    • 8.6 India Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Chimeric Antigen Receptor Cell Therapy Consumption Forecast (2022-2028)

    9 Global Chimeric Antigen Receptor Cell Therapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Combination Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Acute Leukemia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Non-hodgkin's Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Multiple Myeloma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Transplant Rejection Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Chimeric Antigen Receptor Cell Therapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Acute Leukemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Non-hodgkin's Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Transplant Rejection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chimeric Antigen Receptor Cell Therapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chimeric Antigen Receptor Cell Therapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chimeric Antigen Receptor Cell Therapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chimeric Antigen Receptor Cell Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chimeric Antigen Receptor Cell Therapy Market Competitive Analysis

    • 14.1 Gilead Sciences Inc

      • 14.1.1 Gilead Sciences Inc Company Details

      • 14.1.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.2 Nanjing Legend Biotech Co Ltd

      • 14.2.1 Nanjing Legend Biotech Co Ltd Company Details

      • 14.2.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.4 Bristol-Myers Squibb Co

      • 14.4.1 Bristol-Myers Squibb Co Company Details

      • 14.4.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

      • 14.5.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details

      • 14.5.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.6 Takara Bio Inc

      • 14.6.1 Takara Bio Inc Company Details

      • 14.6.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.7 Cellular Biomedicine Group Inc

      • 14.7.1 Cellular Biomedicine Group Inc Company Details

      • 14.7.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.8 NantKwest Inc

      • 14.8.1 NantKwest Inc Company Details

      • 14.8.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.9 Kite Pharma Inc

      • 14.9.1 Kite Pharma Inc Company Details

      • 14.9.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.10 Daiichi Sankyo Co Ltd

      • 14.10.1 Daiichi Sankyo Co Ltd Company Details

      • 14.10.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.11 Autolus Therapeutics Plc

      • 14.11.1 Autolus Therapeutics Plc Company Details

      • 14.11.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.12 Cell Medica Ltd

      • 14.12.1 Cell Medica Ltd Company Details

      • 14.12.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.13 Juno Therapeutics Inc

      • 14.13.1 Juno Therapeutics Inc Company Details

      • 14.13.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.14 CARsgen Therapeutics Ltd

      • 14.14.1 CARsgen Therapeutics Ltd Company Details

      • 14.14.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.15 Celyad SA

      • 14.15.1 Celyad SA Company Details

      • 14.15.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.16 Beijing Immunochina Medical Science & Technology Co Ltd

      • 14.16.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details

      • 14.16.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.17 Hangzhou Converd Co Ltd

      • 14.17.1 Hangzhou Converd Co Ltd Company Details

      • 14.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.18 Ono Pharmaceutical Co Ltd

      • 14.18.1 Ono Pharmaceutical Co Ltd Company Details

      • 14.18.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.19 Sorrento Therapeutics Inc

      • 14.19.1 Sorrento Therapeutics Inc Company Details

      • 14.19.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.20 Hebei Senlang Biotechnology Inc Ltd

      • 14.20.1 Hebei Senlang Biotechnology Inc Ltd Company Details

      • 14.20.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.21 Bellicum Pharmaceuticals Inc

      • 14.21.1 Bellicum Pharmaceuticals Inc Company Details

      • 14.21.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.22 Guangzhou Anjie Biomedical Technology Co Ltd

      • 14.22.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details

      • 14.22.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.23 Celgene Corp

      • 14.23.1 Celgene Corp Company Details

      • 14.23.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.24 Fosun Pharmaceutical AG

      • 14.24.1 Fosun Pharmaceutical AG Company Details

      • 14.24.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.25 Celularity Inc

      • 14.25.1 Celularity Inc Company Details

      • 14.25.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.26 Nkarta Inc

      • 14.26.1 Nkarta Inc Company Details

      • 14.26.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.27 Amgen Inc

      • 14.27.1 Amgen Inc Company Details

      • 14.27.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.28 bluebird bio Inc

      • 14.28.1 bluebird bio Inc Company Details

      • 14.28.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • 14.29 HRAIN Biotechnology Co Ltd

      • 14.29.1 HRAIN Biotechnology Co Ltd Company Details

      • 14.29.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.29.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chimeric Antigen Receptor Cell Therapy

    • Figure Chimeric Antigen Receptor Cell Therapy Picture

    • Table Global Chimeric Antigen Receptor Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chimeric Antigen Receptor Cell Therapy Consumption by Country (2017-2022)

    • Figure United States Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate (2017-2022)

    • Table Europe Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure China Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure India Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chimeric Antigen Receptor Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Consumption Forecast by Country (2022-2028)

    • Figure United States Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chimeric Antigen Receptor Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Leukemia Consumption and Growth Rate (2017-2022)

    • Figure Global Non-hodgkin's Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Myeloma Consumption and Growth Rate (2017-2022)

    • Figure Global Transplant Rejection Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Leukemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-hodgkin's Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transplant Rejection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Export by Region (Top 5 Countries) (2017-2028)

    • Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Nanjing Legend Biotech Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Takara Bio Inc (Foundation Year, Company Profile and etc.)

    • Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Cellular Biomedicine Group Inc (Foundation Year, Company Profile and etc.)

    • Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table NantKwest Inc (Foundation Year, Company Profile and etc.)

    • Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Kite Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Daiichi Sankyo Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Autolus Therapeutics Plc (Foundation Year, Company Profile and etc.)

    • Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Cell Medica Ltd (Foundation Year, Company Profile and etc.)

    • Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Juno Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table CARsgen Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Celyad SA (Foundation Year, Company Profile and etc.)

    • Table Celyad SA Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celyad SA Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Beijing Immunochina Medical Science & Technology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Hangzhou Converd Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Ono Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Sorrento Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Hebei Senlang Biotechnology Inc Ltd (Foundation Year, Company Profile and etc.)

    • Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Bellicum Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Guangzhou Anjie Biomedical Technology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Celgene Corp (Foundation Year, Company Profile and etc.)

    • Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Fosun Pharmaceutical AG (Foundation Year, Company Profile and etc.)

    • Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Celularity Inc (Foundation Year, Company Profile and etc.)

    • Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Nkarta Inc (Foundation Year, Company Profile and etc.)

    • Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table bluebird bio Inc (Foundation Year, Company Profile and etc.)

    • Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product and Service

    • Table HRAIN Biotechnology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US